UNUM THERAPEUTICS INC - COM (UMRX)

CUSIP: 903214104

Q3 2019 13F Holders as of 30 Sep 2019

Type / Class
Equity / COM
Total 13F shares
12,366,949
Share change
-464,497
Total reported value
$17,810,253
Price per share
$1.44
Number of holders
35
Value change
-$1,052,821
Number of buys
12
Number of sells
21

Quarterly Holders Quick Answers

What is CUSIP 903214104?
CUSIP 903214104 identifies UMRX - UNUM THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of UNUM THERAPEUTICS INC - COM (UMRX) as of Q3 2019

As of 30 Sep 2019, UNUM THERAPEUTICS INC - COM (UMRX) was held by 35 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 12,366,949 shares. The largest 10 holders included Atlas Venture Associates IX, LLC, New Leaf Venture Partners, L.L.C., Sectoral Asset Management Inc, CHI Advisors LLC, FIL Ltd, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., VANGUARD GROUP INC, Novo Holdings A/S, and FMR LLC. This page lists 35 institutional shareholders reporting positions in this security for the Q3 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.